We are live on ! Find out more
MCP

Martin Capital Partners Portfolio holdings

AUM $272M
1-Year Est. Return 19.09%
This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+19.09%
3 Year Est. Return
+35.19%
5 Year Est. Return
+47.96%
10 Year Est. Return
–
AUM
$169M
AUM Growth
+$20.6M
Cap. Flow
+$12.7M
Cap. Flow %
7.52%
Top 10 Hldgs %
32.59%
Holding
63
New
10
Increased
44
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$2.93M
2
MRK icon
Merck
MRK
+$2.43M
3
GILD icon
Gilead Sciences
GILD
+$1.68M
4
XOM icon
ExxonMobil
XOM
+$1.51M
5
MSM icon
MSC Industrial Direct
MSM
+$1.38M

Top Sells

Rank Stock Value
1
WBK
Westpac Banking Corporation
WBK
+$2.82M
2
GSK icon
GSK
GSK
+$2.07M
3
AAPL icon
Apple
AAPL
+$1.54M
4
T icon
AT&T
T
+$1.46M
5
MSFT icon
Microsoft
MSFT
+$525K

Sector Composition

Rank Sector Weight
1 Healthcare 17.23%
2 Financials 16.38%
3 Technology 12.35%
4 Consumer Staples 11.19%
5 Energy 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
1
Pfizer
PFE
$140B
$7.16M 4.23%
192,702
+11,174
+6% +$398K
JPM icon
2
JPMorgan Chase
JPM
$939B
$6.06M 3.58%
43,477
+1,666
+4% +$214K
JNJ icon
3
Johnson & Johnson
JNJ
$635B
$5.94M 3.51%
40,751
+1,046
+3% +$142K
AMGN icon
4
Amgen
AMGN
$203B
$5.88M 3.48%
24,398
+1,460
+6% +$322K
CVX icon
5
Chevron
CVX
$388B
$5.4M 3.19%
44,834
+8,366
+23% +$985K
RDS.B
6
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$5.17M 3.05%
86,144
+20,959
+32% +$1.23M
CSCO icon
7
Cisco
CSCO
$450B
$5.09M 3.01%
106,100
+8,758
+9% +$407K
KO icon
8
Coca-Cola
KO
$354B
$4.91M 2.9%
88,614
+4,676
+6% +$251K
UPS icon
9
United Parcel Service
UPS
$97.6B
$4.83M 2.86%
41,289
+1,952
+5% +$231K
VZ icon
10
Verizon
VZ
$194B
$4.7M 2.78%
76,620
+2,102
+3% +$127K
AAPL icon
11
Apple
AAPL
$4.89T
$4.69M 2.77%
63,900
-23,968
-27% -$1.54M
SBUX icon
12
Starbucks
SBUX
$118B
$4.46M 2.64%
50,787
+5,275
+12% +$450K
MSFT icon
13
Microsoft
MSFT
$2.84T
$4.35M 2.57%
27,579
-3,576
-11% -$525K
MSM icon
14
MSC Industrial Direct
MSM
$7.02B
$4.33M 2.56%
55,182
+18,680
+51% +$1.38M
LYG icon
15
Lloyds Banking Group
LYG
$87.4B
$4.17M 2.46%
1,258,660
+52,047
+4% +$157K
XOM icon
16
ExxonMobil
XOM
$651B
$4.11M 2.43%
58,959
+21,785
+59% +$1.51M
SPSB icon
17
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
$4.06M 2.4%
131,688
+999
+0.8% +$30.8K
BNS icon
18
Scotiabank
BNS
$106B
$4.05M 2.39%
71,665
+3,818
+6% +$217K
TXN icon
19
Texas Instruments
TXN
$255B
$4.02M 2.38%
31,347
+1,205
+4% +$149K
USB icon
20
US Bancorp
USB
$99.6B
$4.02M 2.37%
67,754
+3,296
+5% +$191K
PG icon
21
Procter & Gamble
PG
$343B
$4.01M 2.37%
32,120
+898
+3% +$110K
GILD icon
22
Gilead Sciences
GILD
$161B
$3.93M 2.32%
60,446
+25,817
+75% +$1.68M
TROW icon
23
T. Rowe Price
TROW
$25B
$3.59M 2.12%
29,430
+1,621
+6% +$191K
GIS icon
24
General Mills
GIS
$19.2B
$3.56M 2.11%
66,539
+1,855
+3% +$97.7K
IGSB icon
25
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$3.54M 2.09%
66,005
+1,105
+2% +$59.3K
1
2 3

Similar funds

SC
Seldon Capital San Francisco, California $272M AUM 90.68% 1-Year Est. Return
SC
Swan Capital Pensacola, Florida $272M AUM 14.84% 1-Year Est. Return
BLAM
Bourne Lent Asset Management Pawling, New York $272M AUM 30.95% 1-Year Est. Return
TP
TritonPoint Partners Chevy Chase, Maryland $272M AUM
AGP
Autumn Glory Partners Dallas, Texas $272M AUM 20.37% 1-Year Est. Return
SFPG
Stonebridge Financial Planning Group Orlando, Florida $272M AUM 16.91% 1-Year Est. Return
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return
SS
Spinecap SAS Paris, France $272M AUM 23.45% 1-Year Est. Return

Martin Capital Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Martin Capital Partners held 63 positions worth $169M, up 14% from $149M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Martin Capital Partners deployed $12.7M of net new capital in Q4 2019, opening 10 new positions and adding to 44 existing holdings. Its largest new stake was Kellanova: 48,411 shares worth $3.14M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was GSK, an estimated $2.07M trimmed.

  • Martin Capital Partners's largest Q4 2019 buy was Kellanova: 48,411 shares worth $3.14M.
  • Martin Capital Partners added most to Gilead Sciences in Q4 2019, an estimated $1.68M increase.
  • Martin Capital Partners's biggest Q4 2019 reduction was GSK, cutting an estimated $2.07M.
  • Martin Capital Partners fully exited Westpac Banking Corporation in Q4 2019, selling an estimated $2.82M.
  • Martin Capital Partners's ten largest holdings make up 33% of its $169M portfolio in Q4 2019.
  • Martin Capital Partners opened 10 new positions and closed 1 in Q4 2019.
  • Martin Capital Partners's portfolio value rose 14% quarter-over-quarter to $169M.

Based on Martin Capital Partners's 13F filing for Q4 2019, filed 31 Jan 2020.